Tempero Pharmaceuticals,a GSK Company
Jianfei Yang is a senior scientist and a project leader in the Th17/Treg cell company at Tempero Pharmaceuticals, a GSK company. He received a Ph.D. in Pathology from Niigata University School of Medicine in Japan in 1997. He then obtained postdoctoral training in Ken Murphy’s lab at HHMI and Washington University School of Medicine. In the past 15 years, he has been studying the role of CD4+ T helper cells in immunity and diseases. He has 10 years of experience in autoimmune disease research and pharmaceutical drug development. He has published numerous papers and patents. Currently, he is interested in targeting Th17 and/or Treg cells for the treatment of immunological diseases. He has published more than 100 technical papers in international conferences and journals.
Visual signal processing and multimedia networking.